1 |
Hiroyuki, I., E. Susumu, Y. Katsuhiko, H. Takayuki, Y. Kohsho, O. Sadayuki, and K. Takashi. 2007. Protective effects of a hibernation-inducer on hepatocyte injury induced by hypothermic preservation. J. Hepatobiliary Pancreat Surg. 14, 509-513
DOI
ScienceOn
|
2 |
Holcik, M., H. Gibson, and R. G. Korneluk. 2001. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6, 253-261
DOI
ScienceOn
|
3 |
Houston, A. and J. O'Connell. 2004. The Fas signalling pathway and its role in the pathogenesis of cancer. Curr. Opin. Pharmacol. 4, 321-326
DOI
ScienceOn
|
4 |
Howard, A. and S. R. Pelc. 1953. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 6, 261
|
5 |
Hussein, M. R., A. K. Haemel, and G. S. Wood. 2003. Apoptosis and melanoma: molecular mechanisms. J. Pathol. 199, 275-288
DOI
ScienceOn
|
6 |
Khalil, M. L. 2006. Biological activity of bee propolis in health and disease. Asian Pac. J. Cancer Prev. 7, 22-31
|
7 |
Kousyou, Y., Y. Katsuhiko, O. Sadayuki, E. Susumu, F. Junichiro, and K. Takashi. 2003. DADLE protects liver against Ischemia-reperfusion injury in the rat. J. Surgical Res. 114, 72-77
DOI
ScienceOn
|
8 |
Lieberthal, W., J. S. Koh, and J. S. Levine. 1998. Necrosis and apoptosis in acute renal failure. Semin Nephrol. 18, 505-518
|
9 |
Morgan, D. O. 1995. Principles of CDK regulation. Nature 374, 131-134
DOI
ScienceOn
|
10 |
Schwartz, G. K. 2005. Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy. J. Clin. Oncol. 23, 4499-4508
DOI
ScienceOn
|
11 |
Antonsson, B. and J. C. Martinou. 2000. The Bcl-2 protein family. Exp. Cell Res. 256, 50-57
DOI
ScienceOn
|
12 |
Beatrice, B., V. Lorella, G. B. Maria, M. Giovanni, B. Marco, and M. Manuela. 2006. The effect of the enkephalin DADLE on transcription does not depend on opioid receptors. Histochem. Cell Bio. 126, 189-197
DOI
ScienceOn
|
13 |
Butt, A. J., C. E. Caldon, C. M. McNeil, A. Swarbrick, E. A. Musgrove, and R. L. Sutherland. 2008. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv. Exp. Med. Biol. 630, 189-205
DOI
|
14 |
Genovese, C., D. Trani, M. Caputi, and P. P. Claudio. 2006. Cell cycle control and beyond; emerging roles for the retinoblastoma gene family. Oncogene 25, 5201-5209
DOI
ScienceOn
|
15 |
Caldon, C. E., R. J. Daly, R. L. Sutherland, and E. A. Musgrove. 2006. Cell cycle control in breast cancer cells. J. Cell Biochem. 97, 261-274
DOI
ScienceOn
|
16 |
Chiarugi, V., L. Magneli, M. Cinelli, and G. Basi. 1994. Apoptosis and the cell cycle. Cell Mol. Biol. Res. 40, 603-612
|
17 |
Chung, H. K., C. Cheong, J. Song, and H. W. Lee. 2005. Extratelomeric functions of telomerase. Curr. Mol. Med. 5, 233-241
DOI
ScienceOn
|
18 |
Thomas, S. M. 2003. Squirreling away at parkinson's. Drug discovery today 8, 51-52
DOI
ScienceOn
|
19 |
Schwartz, G. K. and M. A. Shah. 2005. Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421
DOI
ScienceOn
|
20 |
Sherr, C. J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689-3695
|
21 |
Wang, D. and R. N. Dubois. 2004. Cyclooxygenase-2: a potential target in breast cancer. Semin. Oncol. 31, 64-73
|
22 |
Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330
DOI
ScienceOn
|